176 related articles for article (PubMed ID: 18483091)
1. Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.
Nayak TK; Hathaway HJ; Ramesh C; Arterburn JB; Dai D; Sklar LA; Norenberg JP; Prossnitz ER
J Nucl Med; 2008 Jun; 49(6):978-86. PubMed ID: 18483091
[TBL] [Abstract][Full Text] [Related]
2. GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding.
Nayak TK; Ramesh C; Hathaway HJ; Norenberg JP; Arterburn JB; Prossnitz ER
Mol Cancer Res; 2014 Nov; 12(11):1635-43. PubMed ID: 25030373
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
[TBL] [Abstract][Full Text] [Related]
4. Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL.
Takahashi N; Yang DJ; Kohanim S; Oh CS; Yu DF; Azhdarinia A; Kurihara H; Zhang X; Chang JY; Kim EE
Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):354-62. PubMed ID: 17021817
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 17-alpha-substituted estradiol-pyridin-2-yl hydrazine conjugates as effective ligands for labeling with Alberto's complex fac-[Re(OH2)3(CO)3]+ in water.
Arterburn JB; Corona C; Rao KV; Carlson KE; Katzenellenbogen JA
J Org Chem; 2003 Sep; 68(18):7063-70. PubMed ID: 12946150
[TBL] [Abstract][Full Text] [Related]
6.
Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
[TBL] [Abstract][Full Text] [Related]
7. Linkage effects on binding affinity and activation of GPR30 and estrogen receptors ERalpha/beta with tridentate pyridin-2-yl hydrazine tricarbonyl-Re/(99m)Tc(I) chelates.
Ramesh C; Bryant B; Nayak T; Revankar CM; Anderson T; Carlson KE; Katzenellenbogen JA; Sklar LA; Norenberg JP; Prossnitz ER; Arterburn JB
J Am Chem Soc; 2006 Nov; 128(45):14476-7. PubMed ID: 17090028
[TBL] [Abstract][Full Text] [Related]
8. Radioiodinated estradiol dimer for estrogen receptor targeted breast cancer imaging.
Xu D; Peng C; Gao F; Guo Z; Zhuang R; Su X; Zhang X
Chem Biol Drug Des; 2020 Dec; 96(6):1332-1340. PubMed ID: 32603003
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential.
Biber FZ; Unak P; Ertay T; Medine EI; Zihnioglu F; Tasci C; Durak H
Appl Radiat Isot; 2006 Jul; 64(7):778-88. PubMed ID: 16531048
[TBL] [Abstract][Full Text] [Related]
10. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.
Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749
[TBL] [Abstract][Full Text] [Related]
11. [125I]17-alpha-iodovinyl 11-beta-methoxyestradiol interaction in vivo with estrogen receptors in hormone-independent MCF-7 human breast cancer transfected with the v-rasH oncogene.
McManaway ME; Jagoda EM; Kasid A; Eckelman WC; Francis BE; Larson SM; Gibson RE; Reba RC; Lippman ME
Cancer Res; 1987 Jun; 47(11):2945-9. PubMed ID: 3567911
[TBL] [Abstract][Full Text] [Related]
12. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a
Tejería ME; Giglio J; Dematteis S; Rey A
J Labelled Comp Radiopharm; 2017 Sep; 60(11):521-527. PubMed ID: 28640526
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a
Tejería E; Giglio J; Fernández L; Rey A
Appl Radiat Isot; 2019 Dec; 154():108854. PubMed ID: 31442798
[TBL] [Abstract][Full Text] [Related]
15. Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents.
Nayak TK; Dennis MK; Ramesh C; Burai R; Atcher RW; Sklar LA; Norenberg JP; Hathaway HJ; Arterburn JB; Prossnitz ER
ACS Chem Biol; 2010 Jul; 5(7):681-90. PubMed ID: 20486699
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
19. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
[TBL] [Abstract][Full Text] [Related]
20. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
